HKIC partners with BioMap to invest in AI life sciences, launch Innovation Hub in Hong Kong.

The Hong Kong Investment Corporation (HKIC) has entered a strategic partnership with BioMap, a company specializing in AI models for the life sciences industry. The agreement aims to accelerate bio-computing development and strengthen Hong Kong's position as a global innovation and technology hub. HKIC will invest in BioMap, which will launch its BioMap Innovation Hub in Hong Kong to support early-stage life science R&D projects. The partnership will focus on sectors such as biopharmaceuticals, green technology, and new industrialisation.